Skip to main content
SpringerLink
Log in

Gefitinib

Gefitinib resistance and transformation from non-small cell lung cancer to small cell lung cancer: case report

Reactions Weekly volume 1580, page 186 (2015)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Reference

  • Xue SP, et al. Clinical observation of translating to small cell lung cancer following treatment with EGFR-Tyrosine kinase inhibitors in lung adenocarcinoma. Chinese Journal of Lung Cancer 18: 656-660, No. 10, Oct 2015. Available from: URL: http://doi.org/10.3779/j.issn.1009-3419.2015.10.10 [Chinese; summarised from translation] - China

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gefitinib. Reactions Weekly 1580, 186 (2015). https://doi.org/10.1007/s40278-015-11532-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-11532-1

search

Navigation